Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres

Gene Therapy

Volumn 13, Issue 18, 2006, Pages 1320-1327

  Hoshino, Kozo ^a,b   Kimura, T ^b   De Grand, A M ^c   Yoneyama, R ^a   Kawase, Y ^a   Houser, S ^a   Ly, H Q ^a   Kushibiki, T ^d   Furukawa, Y ^b   Ono, K ^b   Tabata, Y ^d   Frangioni, J V ^c   Kita, T ^b   Hajjar, R J ^a   Hayase, M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; MICROSPHERE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; CORONARY VEIN; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE; HYDROGEL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; CATHETERIZATION; CORONARY CIRCULATION; CORONARY VESSELS; FIBROBLAST GROWTH FACTOR 2; GELATIN; GENE THERAPY; HYDROGEL; INJECTIONS; MICROSPHERES; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW; STEM CELL TRANSPLANTATION; SWINE;

EID: 33748302970     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302793     Document Type: Article

References (33)

1. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-1402.
2. Hajjar RJ, del Monte F, Matsui T, Rosenzweig A. Prospects for gene therapy for heart failure. Circ Res 2000; 86: 616-621.
3. Donahue JK, Heldman AW, Fraser H, McDonald AD, Miller JM, Rade JJ et al. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med 2000; 6: 1395-1398.
4. Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 1999; 10: 79-94.
5. Kasahara H, Tanaka E, Fukuyama N, Sato E, Sakamoto H, Tabata Y et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. J Am Coll Cardiol 2003; 41: 1056-1062.
6. Nagaya N, Kangawa K, Kanda M, Uematsu M, Horio T, Fukuyama N et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003; 108: 889-895.
7. Tokunaga N, Nagaya N, Shirai M, Tanaka E, Ishibashi-Ueda H, Harada-Shira M et al. Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hind limb ischemia: Benefits of a novel nonviral vector, gelatin. Circulation 2004; 109: 526-531.
8. Hosaka A, Koyama H, Kushibiki T, Tabata Y, Nishiyama N, Miyata T et al. Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels. Circulation 2004; 110: 3322-3328.
9. Sakakibara Y, Tambara K, Sakaguchi G, Lu F, Yamamoto M, Nishimura K et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 2003; 24: 105-111; discussion 112.
10. Hayase M, Del Monte F, Kawase Y, Macneill BD, McGregor J, Yoneyama R et al. Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol 2005; 288: H2995-H3000.
11. Kornowski R, Fuchs S, Leon MB, Epstein SE. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 2000; 101: 454-458.
12. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ. Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv 2002; 55: 392-397.
13. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
14. Arras M, Mollnau H, Strasser R, Wenz R, Ito WD, Schaper J et al. The delivery of angiogenic factors to the heart by microsphere therapy. Nat Biotechnol 1998; 16: 159-162.
15. Boekstegers P, Kupatt C. Current concepts and applications of coronary venous retroinfusion. Basic Res Cardiol 2004; 99: 373-381.
16. Herity NA, Lo ST, Oei F, Lee DP, Ward MR, Filardo SD et al. Selective regional myocardial infiltration by the percutaneous coronary venous route: A novel technique for local drug delivery. Catheter Cardiovasc Interv 2000; 51: 358-363.
17. Fearon WF, Ikeno F, Bailey LR, Hiatt BL, Herity NA, Carter AJ et al. Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein. Catheter Cardiovasc Interv 2004; 61: 422-428.
18. Nakazawa HK, Roberts DL, Klocke FJ. Quantitation of anterior descending vs circumflex venous drainage in the canine great cardiac vein and coronary sinus. Am J Physiol 1978; 234: H163-H166.
19. Hochberg MS, Roberts WC, Morrow AG, Austen WG. Selective arterialization of the coronary venous system. Encouraging long-term flow evaluation utilizing radioactive microspheres. J Thorac Cardiovasc Surg 1979; 77: 1-12.
20. Boekstegers P, Giehrl W, von Degenfeld G, Steinbeck G. Selective suction and pressure-regulated retroinfusion: An effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1998; 31: 1525-1533.
21. von Degenfeld G, Raake P, Kupatt C, Lebherz C, Hinkel R, Gildehaus FJ et al. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol 2003; 42: 1120-1128.
22. Raake P, von Degenfeld G, Hinkel R, Vachenauer R, Sandner T, Beller S et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 2004; 44: 1124-1129.
23. Ortale JR, Gabriel EA, Iost C, Marquez CQ. The anatomy of the coronary sinus and its tributaries. Surg Radiol Anat 2001; 23: 15-21.
24. Thompson CA, Nasseri BA, Makower J, Houser S, McGarry M, Lamson T et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003; 41: 1964-1971.
25. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004; 44: 1690-1699.
26. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
27. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
28. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005; 102: 11474-11479.
29. Chien KR. Stem cells: Lost in translation. Nature 2004; 428: 607-608.
30. Suzuki K, Murtuza B, Fukushima S, Smolenski RT, Varela-Carver A, Coppen SR et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function. Circulation 2004; 110: II225-II230.
31. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 2004; 363: 783-784.
32. Blanton Jr JR, Grant AL, McFarland DC, Robinson JP, Bidwell CA. Isolation of two populations of myoblasts from porcine skeletal muscle. Muscle Nerve 1999; 22: 43-50.
33. De Grand AM, Frangioni JV. An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2003; 2: 553-562.